CANDEL THERAPEUTICS INC's ticker is and the CUSIP is 137404109. A total of 21 filers reported holding CANDEL THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $18,048 | -27.0% | 19,617 | 0.0% | 0.00% | – |
Q2 2023 | $24,717 | -6.7% | 19,617 | 0.0% | 0.00% | – |
Q1 2023 | $26,483 | +2.2% | 19,617 | +35.4% | 0.00% | – |
Q4 2022 | $25,925 | -42.4% | 14,483 | 0.0% | 0.00% | – |
Q3 2022 | $45,000 | -4.3% | 14,483 | 0.0% | 0.00% | – |
Q2 2022 | $47,000 | -30.9% | 14,483 | +7.6% | 0.00% | – |
Q1 2022 | $68,000 | -35.2% | 13,455 | 0.0% | 0.00% | – |
Q4 2021 | $105,000 | – | 13,455 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Northpond Ventures, LLC | 1,935,215 | $6,077,000 | 4.26% |
Sands Capital Ventures, LLC | 811,737 | $2,549,000 | 0.74% |
Empirical Asset Management, LLC | 12,000 | $38,000 | 0.04% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 132,700 | $417,000 | 0.01% |
Point72 Asset Management, L.P. | 403,131 | $1,266,000 | 0.01% |
FRANKLIN RESOURCES INC | 1,125,000 | $3,533,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 96 | $0 | 0.00% |
NORTHERN TRUST CORP | 14,483 | $45,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 128,846 | $404,000 | 0.00% |